financetom
Business
financetom
/
Business
/
Update: Fox's Adjusted Q4 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Fox's Adjusted Q4 Earnings, Revenue Rise
Aug 6, 2024 8:07 AM

10:40 AM EDT, 08/06/2024 (MT Newswires) -- (Updates to include dividend increase in the last paragraph.)

Fox (FOX) reported fiscal Q4 adjusted earnings Tuesday of $0.90 per diluted share, up from $0.88 a year earlier.

Analysts surveyed by Capital IQ expected $0.81.

Revenue for the quarter ended June 30 was $3.09 billion, up from $3.03 billion a year earlier.

Analysts polled by Capital IQ expected $3.10 billion.

The company said its board approved an increased semi-annual dividend of $0.27 per class A and B share, from $0.26 previously, payable on Sept. 25 to shareholders of record as of Sept. 4.

Price: 35.78, Change: +1.74, Percent Change: +5.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AtkinsRealis Appointed Design and Development Partner by UK's United Utilities For Enviro Program
AtkinsRealis Appointed Design and Development Partner by UK's United Utilities For Enviro Program
Oct 2, 2024
08:13 AM EDT, 10/02/2024 (MT Newswires) -- AtkinsRealis Group ( SNCAF ) on Wednesday said it will work with the UK's largest listed water company, United Utillities, to deliver a major environmental program to provide cleaner rivers, more reliable water supplies and better services. The framework will run for five years initially, with an option to extend up to 11...
BioCryst Pharmaceuticals Enrolls First Patient in Phase 1 Trial of BCX17725 to Treat Netherton Syndrome
BioCryst Pharmaceuticals Enrolls First Patient in Phase 1 Trial of BCX17725 to Treat Netherton Syndrome
Oct 2, 2024
07:30 AM EDT, 10/02/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Wednesday that the first participant has been enrolled in a phase 1 trial evaluating BCX17725 to treat patients with Netherton syndrome, a rare, lifelong genetic disorder affecting the skin, hair and immune system. The trial will evaluate the safety, tolerability, pharmacokinetics and immunogenicity of the drug candidate....
CGI Federal Wins Spot on $2 Billion US Interior Cloud Hosting Services Contract
CGI Federal Wins Spot on $2 Billion US Interior Cloud Hosting Services Contract
Oct 2, 2024
07:30 AM EDT, 10/02/2024 (MT Newswires) -- CGI (GIB) subsidiary CGI Federal said Wednesday it has won a position on the US Department of the Interior's 10-year, $2 billion Foundation Cloud Hosting Services II contract. Under the deal, CGI will provide cloud services and solutions to support the department's modernization efforts, CGI Federal said. Price: 114.20, Change: -0.02, Percent Change:...
--Street Color: Starbucks CEO Brian Niccol Eliminates Global Chief Merchant, Product Officer Role, Bloomberg Reports
--Street Color: Starbucks CEO Brian Niccol Eliminates Global Chief Merchant, Product Officer Role, Bloomberg Reports
Oct 2, 2024
07:32 AM EDT, 10/02/2024 (MT Newswires) -- Price: 97.53, Change: +0.10, Percent Change: +0.10 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved